Intraarticular Corticosteroids for Hip Osteoarthritis: A Review. (December 2021)

• Record Type: Journal Article
• Authors: Choueiri, Magda; Chevalier, Xavier; Eymard, Florent
• Is Part Of: Cartilage. Volume 13:Number 1(2022)Supplement
• Page Start: 122S
• Page End: 131S
• Publication Date: 2021-12
• Subjects: corticosteroid -- hip -- osteoarthritis -- efficacy and tolerability; Cartilage -- Periodicals; 616.7
• DOI: 10.1177/1947603520951634
• Languages: English
• ISSNs: 1947-6035

Abstract

Introduction: Hip osteoarthritis is a prevalent condition responsible for important pain and disability. Most available guidelines for nonsurgical management of hip osteoarthritis recommend a combination of nonpharmacological and pharmacological treatment modalities. Intraarticular corticosteroid injections have been used for decades, although evidence is quite scarce, and many controversies remain. Methods: This article reviews the available literature from Medline and Embase and discusses the evidence for intraarticular corticosteroid injections in hip osteoarthritis, where only 5 randomized controlled trials were found in the literature. These are analyzed in this article, which also aims to explain the main characteristics and features of glucocorticoids, along with their contraindications and potential adverse effects. Results: Available randomized controlled trials show that intraarticular corticosteroid injections provide pain relief and functional improvement in hip osteoarthritis. This efficacy has not been shown with intraarticular hyaluronic acid injections. Conclusion: This review shows that intraarticular corticosteroid injections are efficacious in hip osteoarthritis and that this benefit can last up to 12 weeks.